Andrew Mulberg

Inga fler pågående positioner

Consumer Services

Health Technology

Government

Profil

Andrew E.
Mulberg is currently SVP-Regulatory Affairs & Quality Assurance at Neurogene, Inc. since 2020.
Formerly, Dr. Mulberg was Division Deputy Director-Gastroenterology at the US Food & Drug Administration and Vice President-Regulatory Affairs at Amicus Therapeutics, Inc. Education includes an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate from Icahn School of Medicine at Mount Sinai.

Aktiva positioner av Andrew Mulberg

Företag	Position	Start

Alla aktiva positioner av Andrew Mulberg

Tidigare kända positioner av Andrew Mulberg

Företag	Position	Slut
US Food & Drug Administration US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services	Företagsledare/Principal	-
AMICUS THERAPEUTICS, INC.	Generell Rådgivare	-

Se detaljerna i Andrew Mulbergs erfarenhet

Andrew Mulbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Andrew Mulbergs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
US Food & Drug Administration US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services	Government
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services